Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

Bcl 2 (B Cell Leukemia 2) (MaxLight 650)

Product Sizes
100ul
£1055.00
B0807-05A-ML650-100UL
About this Product
SKU:
B0807-05A-ML650
Application:
Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Immunoprecipitation, FLISA
translate.label.attr.clone:
3G15 (Bcl-2–100)
Clonality:
Monoclonal
Extra Details:
MaxLight™ 650 is a new Far-IR stable dye conjugate comparable to Alexa Fluor™647, DyLight™649, Cy5™ and offers better labeling efficiency, brighter imaging and increased immunodetection. Absorbance (655nm); Emission (676nm); Extinction Coefficient 250,000. Bcl-2 is a widely studied modulator of programmed cell death (apoptosis) in lymphoid cells. This 26kD integral membrane protein has been localized to several distinct subcellular locations including: the outer mitochondrial membrane, perinuclear membrane and the smooth endoplasmic reticulum. Overexpression of the Bcl-2 protein has been shown to prevent or delay many forms of programmed cell death induced by a variety of different stimuli including: growth factor deprivation, g-irradiation, glucocorticoids, and chemotherapeutic agents. The bcl-2 proto-oncogene was first identified at the breakpoint region of the t(14;18) chromosomal translocation found in a large percentage (85%) of human follicular B-cell lymphomas. This translocation results in transcriptional dysregulation of the bcl-2 gene and overexpression of the Bcl-2 protein. Originally, expression of the Bcl-2 protein was thought to be restricted to neoplastic cells in which the t(14;18) chromosomal translocation was present. However, subsequent studies demonstrated that Bcl-2 is in fact expressed in both normal T- and B-cells, as well as in a variety of lymphoproliferative disorders in which the t(14;18) translocation is not present. Expression of the Bcl-2 protein has been found to be regulated in a stage-specific manner during lymphoid development and is thought to be a survival signal for positive selection. However, the precise mechanism whereby Bcl-2 acts to inhibit programmed cell death remains to be elucidated. Applications: Suitable for use in FLISA, Flow Cytometry, Immunofluorescence, Immunocytochemistry, Western Blot, Immunoprecipitation and Immunohistochemistry. Other applications not tested. Recommended Dilutions: Immunohistochemistry: Frozen and paraffin sections Optimal dilutions to be determined by the researcher. Storage and Stability: Store product at 4°C in the dark. DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight™650 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Note: Applications are based on unconjugated antibody.
Host:
Mouse
Immunogen:
Synthetic peptide corresponding to residues 41-54 of the human Bcl-2 protein. This sequence is not shared by the mouse Bcl-2 protein.
Isotype:
IgG1,k
Physical State:
Supplied as a liquid in PBS, pH 7.2. No preservatives added. Labeled with MaxLight™650.
Purity:
Purified by Protein A affinity chromatography.
Shipping Conditions:
Blue Ice
Specificity:
Recognizes human Bcl-2 protein and does not exhibit crossreactivity with other proteins. The Bcl-2 protein has been detected in human Jurkat cell lysate, human K562 cell lysate, human tonsil tissue.
Source:
human
Storage Conditions:
4[o]C Do Not Freeze
Type:
Antibodies:Monoclonal Antibody